Report : North America Platelet Rich Plasma Tube Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Usage (Skin Rejuvenation, Hair Restoration, Orthopedics, Surgical Oncology, Gynecology, and Others), Volume (Less Than 5 ML, 6 ML TO 10 ML, and More Than 10 ML), and End User (MedSpas, Dermatology Offices, Hospitals and Healthcare Practices, Tricologist Practices, and Others)

At 16.2% CAGR, the North America Platelet Rich Plasma Tube Market is speculated to be worth US$ 642.10 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the North America platelet rich plasma tube market was valued at US$ 261.11 million in 2022 and is expected to reach US$ 642.10 million by 2028, registering a CAGR of 16.2% from 2022 to 2028. Growing number of medical spas and rising number of cosmetic and aesthetic procedures are the critical factors attributed to the North America platelet rich plasma tube market expansion.

The US currently holds 37.72% of the global medspa market. According to the American Med Spa Association, the most popular procedures at medspas involve injections. The procedures include micro-needling for skin tightening and acne scars removal. According to Pillsbury Insights, the medical spa (medspa) industry in the US is booming. In 2010, about 1,600 medspas were operating in the country, generating about US $1.1 billion in revenue (about US $700,000 per medspa on average). By 2018, these numbers increased to over 5,000 medspas generating about US $7 –$8 billion in revenue (about US $1.4 million per medspa on average). The number is expected to grow to over 10,000 medspas by 2023, with about US $18–$20.7 billion in revenue. Furthermore, a wellness program in Oman has incorporated traditional healing practices and pampering treatments that include a hammam and natural hot springs.

On the contrary, high cost and adverse effects of platelet-rich plasma treatment hurdles the growth of North America platelet rich plasma tube market.

Based on usage, the North America platelet rich plasma tube market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. The others segment held 25.1% share of North America platelet rich plasma tube market in 2022, amassing US$ 65.50 million. It is projected to garner US$ 156.65 million by 2028 to expand at 15.6% CAGR during 2022–2028.

Based on volume, the North America platelet rich plasma tube market is segmented into less than 5 ml, 6ml to 10 ml, and more than 10 ml. The more than 10 ml segment held 62.3% share of North America platelet rich plasma tube market in 2022, amassing US$ 162.62 million. It is projected to garner US$ 394.03 million by 2028 to expand at 15.9% CAGR during 2022–2028.

Based on end user, the North America platelet rich plasma tube market is segmented into medspa, dermatology office, hospitals & healthcare practice, tricologist, and others. The hospitals & healthcare practice segment held 35.0% share of North America platelet rich plasma tube market in 2022, amassing US$ 91.49 million. It is projected to garner US$ 223.96 million by 2028 to expand at 16.1% CAGR during 2022–2028.

Based on country, the North America platelet rich plasma tube market has been categorized into the US, Canada, and Mexico.  Our regional analysis states that the US captured 83.5% share of North America platelet rich plasma tube market in 2022. It was assessed at US$ 218.02 million in 2022 and is likely to hit US$ 543.86 million by 2028, exhibiting a CAGR of 16.5% during the forecast period.

Key players profiles in the North America platelet rich plasma tube market report AdvaCare Pharma USA LLC; ADVIN HEALTH CARE; BIO-X; Emerging Medical Group LLC; Henso Medical (Hangzhou) Co Ltd; Integrity PRP; Juventix Regenerative Medical LLC; and Manso Medical Co Ltd, among others.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com

Download Free PDF Brochure